AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium Cyclosilicate
- 11 September 2025
- 1 week ago
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITC
- 09 September 2025
- 1 week ago
Recent News
Doctors undergoing PG medical courses without join...
- 18 September, 2025
TN Nursing admissions 2025: Check out round 2 sche...
- 18 September, 2025
AIIMS Rishikesh notifies reporting guidelines for...
- 18 September, 2025
'Stipend cannot be given to FMG Interns'- says Guj...
- 18 September, 2025
MCC NEET 2025 Round 2 Counselling Final Results OU...
- 18 September, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.